# US 2023/0069218 A1 · Method for producing peptide containing non-natural amino acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0069218 A1
- Document ID: US20230069218A1
- Status: Published application
- Kind: A1
- Application number: 17/783,076
- Filed: 2020-12-11
- Published: 2023-03-02
- Earliest claimed: 2019-12-12
- Assignees: Chugai Seiyaku Kabushiki Kaisha
- Applicants: Chugai Seiyaku Kabushiki Kaisha
- Inventors: Sakiko YOSHII; Koichiro SHIMOMURA; Sou ISHINO
- Web page: https://patentgrep.com/patent/US20230069218A1

## CPC

- C07K 14/245: Escherichia (G)
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/1062: {mRNA-Display, e.g. polypeptide and encoding template are connected covalently}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/67: General methods for enhancing the expression
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C40B 30/04: by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- C40B 40/08: Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 2500/02: Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention revealed that translating an mRNA that encodes a peptide containing an unnatural amino acid in a translation system that contains a ribosome containing an engineered L31 protein can increase the amount of the translated peptide. Furthermore, the invention revealed that by using this ribosome, the relative amount of by-products can also be reduced. An engineered L31 protein of the present invention has an amino acid sequence with deletion of 6 or more amino acid residues from the C terminus in the amino acid sequence of the wild-type Escherichia coli L31 protein.

## Claims

### Claim 1

A method for producing a peptide, comprising a step of translating an mRNA encoding a peptide comprising one or more types of unnatural amino acids in a translation system that comprises a ribosome comprising an engineered L31 protein, wherein the ribosome comprising the engineered L31 protein has greater activity for translation of the peptide comprising the unnatural amino acids, as compared to a ribosome comprising wild-type Escherichia coli L31 that comprises the amino acid sequence of SEQ ID NO: 1.

### Claim 2

A method for producing a peptide, comprising a step of translating an mRNA encoding a peptide comprising one or more types of unnatural amino acids in a translation system that comprises a ribosome comprising an engineered L31 protein, wherein the engineered L31 protein is selected from the group consisting of the proteins of (1) to (3) below:
(1) a protein comprising an amino acid sequence with deletion of 6 or more amino acid residues from the C terminus in the amino acid sequence set forth in SEQ ID NO: 1;
(2) a protein comprising an amino acid sequence with one or more amino acid insertions, substitutions, deletions, and/or additions in the amino acid sequence of the protein of (1); and
(3) a protein comprising an amino acid sequence having 80% or more sequence identity to the amino acid sequence of the protein of (1).

### Claim 3 (depends on 2)

The method of claim 2, wherein the ribosome comprising the protein of (2) and (3) has greater activity for translation of the peptide comprising the unnatural amino acids, as compared to the ribosome comprising the wild-type Escherichia coli L31 that comprises the amino acid sequence of SEQ ID NO: 1.

### Claim 4 (depends on 1)

The method of claim 1, wherein the proportion of ribosomes comprising the engineered L31 protein relative to all ribosomes in the translation system is 50% or more.

### Claim 5 (depends on 1)

The method of claim 1, further comprising a step of cyclizing the peptide.

### Claim 6 (depends on 1)

The method of claim 1, wherein the peptide comprises an unnatural amino acid at a position corresponding to its initial amino acid.

### Claim 7 (depends on 1)

A method of screening for a peptide that binds to a target substance, comprising steps (a) to (c) below:
(a) producing a peptide by the method of claim 1
(b) contacting a target substance with the peptide or a library comprising the peptides; and
(c) selecting a peptide that binds to the target substance.

### Claim at position 8

-45. (canceled)

### Claim 16 (depends on 2)

The method of claim 2, wherein the proportion of ribosomes comprising the engineered L31 protein relative to all ribosomes in the translation system is 50% or more.

### Claim 17 (depends on 2)

A method of screening for a peptide that binds to a target substance, comprising steps (a) to (c) below:
(a) producing a peptide by the method of claim 2;
(b) contacting a target substance with the peptide or a library comprising the peptides; and
(c) selecting a peptide that binds to the target substance.

### Claim 18

A engineered L31 protein selected from the group consisting of the proteins of (1) to (3) below:
(1) a protein comprising an amino acid sequence with deletion of 9 or more amino acid residues from the C terminus in the amino acid sequence set forth in SEQ ID NO: 1;
(2) a protein comprising an amino acid sequence in which 1 to 9 amino acid(s) are inserted, substituted, deleted and/or added in the amino acid sequence of the protein described in the above (1); and
(3) a protein comprising an amino acid sequence having 90% or more sequence identity to the amino acid sequence of the protein of (1).

### Claim 19 (depends on 18)

The engineered L31 protein of claim 18, wherein the ribosome comprising the protein of (2) and (3) has greater activity for translation of the peptide comprising the unnatural amino acids, as compared to a ribosome comprising wild-type Escherichia coli L31 that comprises the amino acid sequence of SEQ ID NO: 1.

### Claim 20 (depends on 18)

An isolated nucleic acid encoding the engineered L31 protein of claim 18.

### Claim 21 (depends on 20)

A vector or cell comprising the nucleic acid of claim 20.

### Claim 22 (depends on 21)

A method for producing a ribosome comprising an engineered L31 protein, comprising steps (a) to (c) below:
(a) culturing the cell of claim 21;
(b) producing a lysate from culture of the cell; and
(c) purifying a ribosome from the lysate.

### Claim 23 (depends on 18)

A ribosome comprising the engineered L31 protein of claim 18.

### Claim 24 (depends on 23)

A composition comprising the ribosome of claim 23.

### Claim 25 (depends on 22)

A method for producing a cell-free translation system, comprising the steps of:
(a) producing a ribosome by the method of claim 22; and
(b) mixing the ribosome and an initiator tRNA acylated with an unnatural amino acid.

### Claim 26

A method for producing a cell-free translation system, comprising the steps of:
(a) producing a lysate from a wild-type Escherichia coli culture using a French press under a condition where the magnesium ion concentration is 5 mM or less,
(b) purifying a ribosome from the lysate; and
(c) mixing the ribosome and an initiator tRNA acylated with an unnatural amino acid.

### Claim 27 (depends on 26)

A method for producing a peptide, comprising steps (i) and (ii) below:
(i) producing a cell-free translation system by the method of claim 26; and
(ii) translating an mRNA encoding a peptide comprising one or more types of unnatural amino acids in the cell-free translation system.

### Claim 28 (depends on 27)

A method of screening for a peptide that binds to a target substance, comprising steps (I) to (III) below:
(I) producing a peptide by the method of claim 27;
(II) contacting a target substance with the peptide or a library comprising the peptides; and
(III) selecting a peptide that binds to the target substance.
